{
    "root": "8e78eabf-6ff9-409b-ba1b-d9cb8d4f3fe0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "SEROQUEL",
        "suffix": {
            "text": "XR"
        }
    },
    "value": "20250122",
    "ingredients": [
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        }
    ],
    "indications": "seroquel xr atypical antipsychotic indicated treatment : \u2022 schizophrenia ( 1.1 ) \u2022 bipolar disorder , manic , mixed episodes ( 1.2 ) \u2022 bipolar disorder , depressive episodes ( 1.2 ) \u2022 major depressive disorder , adjunctive therapy antidepressants ( 1.3 )",
    "contraindications": "\u2022 swallow tablets whole split , chew crush ( 2.1 ) \u2022 take without food light meal ( approx . 300 calories ) ( 2.1 ) \u2022 administer daily , preferably evening ( 2.1 ) \u2022 geriatric : consider lower starting dose ( 50 mg/day ) , slower titration , careful monitoring initial dosing period elderly ( 2.3 , 8.5 ) \u2022 hepatic impairment : lower starting dose ( 50 mg/day ) slower titration may needed ( 2.4 , 8.7 , 12.3 ) indication initial dose recommended dose maximum dose schizophrenia - adults ( 2.2 ) 300 mg/day 400-800 mg/day 800 mg/day schizophrenia - adolescents ( 13 17 years ) ( 2.2 ) 50 mg/day 400-800 mg/day 800 mg/day bipolar disorder manic mixed - acute monotherapy adjunct lithium divalproex - adults ( 2.2 ) 300 mg/day 400-800 mg/day 800 mg/day bipolar disorder , manic acute monotherapy - children adolescents ( 10 17 years ) ( 2.2 ) 50 mg/day 400-600 mg/day 600 mg/day bipolar disorder , depressive episodes - adults ( 2.2 ) 50 mg/day 300 mg/day 300 mg/day major depressive disorder , adjunctive therapy antidepressants - adults ( 2.2 ) 50 mg/day 150-300 mg/day 300 mg/day",
    "warningsAndPrecautions": "\u202250 mg tablets ( ndc 0310-0280-60 ) peach , film-coated , capsule-shaped , biconvex , intagliated tablet \u201c xr 50 \u201d one side plain supplied bottles 60 tablets . \u2022150 mg tablets ( ndc 0310-0281-60 ) white , film-coated , capsule-shaped , biconvex , intagliated tablet \u201c xr 150 \u201d one side plain supplied bottles 60 tablets . \u2022200 mg tablets ( ndc 0310-0282-60 ) yellow , film-coated , capsule-shaped , biconvex , intagliated tablet \u201c xr 200 \u201d one side plain supplied bottles 60 tablets . \u2022300 mg tablets ( ndc 0310-0283-60 ) pale yellow , film-coated , capsule-shaped , biconvex , intagliated tablet \u201c xr 300 \u201d one side plain supplied bottles 60 tablets . \u2022400 mg tablets ( ndc 0310-0284-60 ) white , film-coated , capsule-shaped , biconvex , intagliated tablet \u201c xr 400 \u201d one side plain supplied bottles 60 tablets . store seroquel xr 25\u00bac ( 77\u00baf ) ; excursions permitted 15-30\u00bac ( 59-86\u00baf ) [ usp ] .",
    "adverseReactions": "hypersensitivity quetiapine excipients seroquel xr formulation . anaphylactic reported patients treated seroquel xr .",
    "indications_original": "SEROQUEL XR is an atypical antipsychotic indicated for the treatment of: \u2022 Schizophrenia (1.1) \u2022 Bipolar I disorder, manic, or mixed episodes (1.2) \u2022 Bipolar disorder, depressive episodes (1.2) \u2022 Major depressive disorder, adjunctive therapy with antidepressants (1.3)",
    "contraindications_original": "\u2022 Swallow tablets whole and do not split, chew or crush (2.1) \u2022 Take without food or with a light meal (approx. 300 calories) (2.1) \u2022 Administer once daily, preferably in the evening (2.1) \u2022 Geriatric Use: Consider a lower starting dose (50 mg/day), slower titration, and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) \u2022 Hepatic Impairment: Lower starting dose (50 mg/day) and slower titration may be needed ( 2.4 , 8.7 , 12.3 ) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia - Adults (2.2) 300 mg/day 400-800 mg/day 800 mg/day Schizophrenia - Adolescents (13 to 17 years) (2.2) 50 mg/day 400-800 mg/day 800 mg/day Bipolar I Disorder manic or mixed - Acute monotherapy or adjunct to lithium or divalproex - Adults (2.2) 300 mg/day 400-800 mg/day 800 mg/day Bipolar I Disorder, manic Acute monotherapy - Children and Adolescents (10 to 17 years) (2.2) 50 mg/day 400-600 mg/day 600 mg/day Bipolar Disorder, Depressive Episodes - Adults (2.2) 50 mg/day 300 mg/day 300 mg/day Major Depressive Disorder, Adjunctive Therapy with Antidepressants - Adults (2.2) 50 mg/day 150-300 mg/day 300 mg/day",
    "warningsAndPrecautions_original": "\u202250 mg Tablets (NDC 0310-0280-60) peach, film-coated, capsule-shaped, biconvex, intagliated tablet with \u201cXR 50\u201d on one side and plain on the other are supplied in bottles of 60 tablets.\n                     \n                        \u2022150 mg Tablets (NDC 0310-0281-60) white, film-coated, capsule-shaped, biconvex, intagliated tablet with \u201cXR 150\u201d on one side and plain on the other are supplied in bottles of 60 tablets.\n                     \n                        \u2022200 mg Tablets (NDC 0310-0282-60) yellow, film-coated, capsule-shaped, biconvex, intagliated tablet with \u201cXR 200\u201d on one side and plain on the other are supplied in bottles of 60 tablets.\n                     \n                        \u2022300 mg Tablets (NDC 0310-0283-60) pale yellow, film-coated, capsule-shaped, biconvex, intagliated tablet with \u201cXR 300\u201d on one side and plain on the other are supplied in bottles of 60 tablets.\n                     \n                        \u2022400 mg Tablets (NDC 0310-0284-60) white, film-coated, capsule-shaped, biconvex, intagliated tablet with \u201cXR 400\u201d on one side and plain on the other are supplied in bottles of 60 tablets.\n                  \n                  Store SEROQUEL XR at 25\u00baC (77\u00baF); excursions permitted to 15-30\u00baC (59-86\u00baF) [See USP].",
    "adverseReactions_original": "Hypersensitivity to quetiapine or to any excipients in the SEROQUEL XR formulation. Anaphylactic reactions have been reported in patients treated with SEROQUEL XR."
}